feed,title,long_url,short_url
Benzinga,"Pharmacogenetics Testing in Psychiatry/Depression Market Will Rise at a CAGR 9.5% by 2029 and is segmented by Test Type, Gene Type, Patient Type, Product, End User and Distribution Channel",https://benzinga.com/pressreleases/22/09/g28828146/pharmacogenetics-testing-in-psychiatrydepression-market-will-rise-at-a-cagr-9-5-by-2029-and-is-seg,
